Sanjaya Singh

Sanjaya Singh is a seasoned biopharmaceutical executive with extensive experience in drug discovery and development. Currently serving as Chief Scientific Officer and Founder of Third Arc Bio since January 2022, Sanjaya is also a Venture Partner at Omega Funds and a Co-Founder and Scientific Advisory Board member at Aliada Therapeutics. Prior roles include Vice President and Global Head of Janssen Biotherapeutics at The Janssen Pharmaceutical Companies of Johnson & Johnson and various leadership positions at Boehringer Ingelheim. Sanjaya's notable contributions to the field include the development of several therapeutic antibodies and biologics. Sanjaya holds a Ph.D. in Zoology from Banaras Hindu University and completed postdoctoral work at UT MD Anderson Cancer Center.